List your company

T-Cell-Targeted LNPs for In Situ CAR T Programming

Drug discovery and biotech · by Kernal Biologics

T-Cell-Targeted LNPs (lipid nanoparticles) for in situ CAR T programming, enabling targeted delivery to T-cells for in vivo CAR-T therapy generation.

Visit website

What it does

T-Cell-Targeted LNPs (lipid nanoparticles) for in situ CAR T programming, enabling targeted delivery to T-cells for in vivo CAR-T therapy generation. Referenced in ASGCT 2026 showcase news.

  • In vivo CAR-T therapies for cancer
  • In vivo CAR-T therapies for autoimmune diseases
Category
Drug discovery and biotech
Users
Patients with cancer, Patients with autoimmune diseases
Public API
Not offered

Not yet disclosed: deployment options, platforms, languages and support channels.

Pricing

Pricing isn't published

Kernal Biologics doesn't list prices publicly. Ask them for a quote.

Security and compliance

No security details published yet

Kernal Biologics hasn't published certifications or security practices for T-Cell-Targeted LNPs for In Situ CAR T Programming that we could find. Ask their team for audit reports.

Reviews

No reviews yet

Reviews come from people who use T-Cell-Targeted LNPs for In Situ CAR T Programming at work. Share how your team uses it to help other buyers decide.

Write a review

Alternatives

  • ITO™ Platform

    by 1910

    Cloud-based end-to-end platform integrating massive multimodal data, frontier AI models, and high-throughput lab automation to deliver small and large molecule drug candidates f...

  • Statistical Programming

    by Enjamb Labs

    Python and R agents for data cleaning, testing, visualization, documentation, and quality-checking statistical outputs including SDTM, ADaM, and TFLs.

  • Integrations

    by Invert

    Pre-built connectivity to every instrument, historian, ELN/LIMS, and enterprise data store that matters in bioprocess.

  • Duoseq

    All-in-one cancer genomics platform performing combined DNA and RNA profiling from a single sample, delivering comprehensive molecular reports on-site within two days.

  • Peristaltic Pump

    by Bramante Biologics Corporation

    Peristaltic pump instrument, API-ready out of the box.

  • COVID Moonshot

    by PostEra

    COVID Moonshot initiative with a dedicated page; no further descriptive detail available from supplied evidence.

Is this your product?

Claim it to keep details accurate and submit evidence for the next ranking review.

Claim T-Cell-Targeted LNPs for In Situ CAR T Programming